Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Guardiola-Capón
J. Guardiola-Capón
Medicine
Adalimumab
Physical therapy
Internal medicine
Diabetes mellitus
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P642 Serum adalimumab levels measured between days 9 and 13 from drug injection can be interpreted clinically in a similar way to trough levels in patients with inflammatory bowel disease
2020
Journal of Crohns & Colitis
J. Guardiola-Capón
K Serra
Lorena Rodríguez-Alonso
E Santacana
N Padullés
Alexandra Ruiz-Cerulla
C Arajol
B. Camps
G. Suris
Elena Sánchez
Francisco Rodriguez-Moranta
Show All
Source
Cite
Save
Citations (0)
P711 Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to adalimumab in patients with Crohn’s disease
2020
Journal of Crohns & Colitis
J. Guardiola-Capón
K Serra
Lorena Rodríguez-Alonso
E Santacana
A. Padró
N Padullés
Alexandra Ruiz-Cerulla
C Arajol
B. Camps
G. Suris
J. Orobitg
Francisco Rodriguez-Moranta
Show All
Source
Cite
Save
Citations (2)
P170 Planar radiolabelled white cell scintigraphy and Technetium-99m-HMPAO labeled leukocyte single photon emission computed tomography (SPECT) for assessing endoscopic remission in ulcerative colitis
2014
Journal of Crohns & Colitis
Claudia Arajol
O. Puig Calvo
Francisco Rodriguez-Moranta
Lorena Rodríguez-Alonso
Alexandra Ruiz-Cerulla
Triana Lobatón
Alicia López-García
J Martín-Comín
J. Guardiola-Capón
Show All
Source
Cite
Save
Citations (0)
1